Structural Heart
Mitral repair, replacement, and transcatheter therapies
Synthesized from 149 evidence-backed clinical questions linked to this topic — 4 supporting the intervention, 7 against the intervention, 2 still contested.
Does mitral valve repair (mvr) vs placebo improve outcomes in CARDIOMYOPATHY, FAMILIAL, WITH CONDUCTION DISTURBANCE?
Low Certainty− Favors harmmitral valve repair (mvr) vs placebo
2 studies (8,330 patients) provide low-certainty evidence against benefit of mitral valve repair (mvr) for the outcome in CARDIOMYOPATHY, FAMILIAL, WITH CONDUCTION DISTURBANCE.
Does cabg + mvr vs placebo improve outcomes in Ischemic cardiomyopathy?
Low Certainty+ Favors benefitcabg + mvr vs placebo
2 studies (705 patients) provide low-certainty evidence for benefit of cabg + mvr for the outcome in Ischemic cardiomyopathy.
Does levosimendan vs placebo improve outcomes in Mitral Valve Insufficiency?
Low Certainty− Favors harmlevosimendan vs placebo
7 studies (396 patients) provide low-certainty evidence against benefit of levosimendan for the outcome in Mitral Valve Insufficiency.
Does mitral valve repair vs placebo improve outcomes in idiopathic acute mitral regurgitation?
Low Certainty− Favors harmmitral valve repair vs placebo
2 studies (287 patients) provide low-certainty evidence against benefit of mitral valve repair for the outcome in idiopathic acute mitral regurgitation.
Does lbbap-crt vs placebo improve outcomes in Heart failure?
Low Certainty− Favors harmlbbap-crt vs placebo
3 studies (276 patients) provide low-certainty evidence against benefit of lbbap-crt for the outcome in Heart failure.
Does mitraclip vs placebo improve outcomes in Mitral Valve Insufficiency?
Low Certainty− Favors harmmitraclip vs placebo
5 studies (179 patients) provide low-certainty evidence against benefit of mitraclip for the outcome in Mitral Valve Insufficiency.
Does shr-1918 vs placebo improve outcomes in Healthy Volunteers?
Insufficient~ Mixed resultsshr-1918 vs placebo · Serum Uric Acid
2 studies (144 patients) provide insufficient evidence with mixed findings regarding shr-1918 for Serum Uric Acid in Healthy Volunteers.
Does mitraclip g4 system vs placebo improve outcomes in Mitral Valve Insufficiency?
Insufficient~ Mixed resultsmitraclip g4 system vs placebo
2 studies (1,202 patients) provide insufficient evidence with mixed findings regarding mitraclip g4 system for the outcome in Mitral Valve Insufficiency.
Emerging evidence with 100 primary claims
Specific, answerable questions in this area — each with its own synthesized evidence and consensus. Open one to see the forest plot, source trials, and how the consensus has changed over time.
Does shr-1918 vs placebo improve LDL Cholesterol in Healthy Volunteers?
Low Certainty+ Favors benefitshr-1918 vs placebo · LDL Cholesterol
Does dipyridamole vs placebo improve Left Ventricular Ejection Fraction in Aortic Valve Stenosis?
Low Certainty− Favors harmdipyridamole vs placebo · Left Ventricular Ejection Fraction
Coronary Angioplasty for Acute Mitral Regurgitation Due to Myocardial Infarction
Annals of Internal Medicine — Heuser R — Dec 1987
The Impact of Surgical Ventricular Restoration on Ischemic Mitral Regurgitation
Medicina — Butkuvienė I — Apr 2011
The Incremental Value of Regional Dyssynchrony in Determining Functional Mitral Regurgitation Beyond Left Ventricular Geometry after Narrow QRS Anterior Myocardial Infarction: A Real Time Three-Dimensional Echocardiography Study
Echocardiography — Hung C — Jul 2011
Mitral regurgitation during a myocardial infarction – New predictors and prognostic significance at two years of follow-up
Acute Cardiac Care — Barra S — Feb 2012
Impact of Functional Tricuspid Regurgitation on Heart Failure and Death in Patients with Functional Mitral Regurgitation and Left Ventricular Dysfunction
Follow this topic to get a weekly “what changed” evidence digest and alerts when journal clubs schedule sessions on it.
Mitral valve intervention (also known as mitral valve repair, TEER, MitraClip). Mitral repair, replacement, and transcatheter therapies
Synapse tracks 2 specific clinical questions in Mitral valve intervention, each synthesized independently from its own trial evidence. They include: "Does shr-1918 vs placebo improve LDL Cholesterol in Healthy Volunteers?"; "Does dipyridamole vs placebo improve Left Ventricular Ejection Fraction in Aortic Valve Stenosis?".
As of 2026-08-14, the scientific consensus on Mitral valve intervention is emerging. Emerging evidence with 100 primary claims Based on 100 analyzed claims across Synapse's enriched corpus, the evidence shows.
This evidence brief synthesizes Synapse's enriched cardiology corpus; cite as synapsesocial.com/topics/mitral-valve-intervention.
Deterministic synthesis from Synapse's enriched corpus — 101 words. No AI-generated novel content; every figure is sourced from the underlying paper, guideline, or trial record linked on this page.
Explore every Mitral valve intervention paper on Synapse with AI-enriched clinical evidence, PICO analysis, and methodology classification.
Search Mitral valve intervention papersPowered by Synapse — AI-enriched analysis of 600,000+ peer-reviewed papers
European Journal of Heart Failure — Agricola E — May 2012